Cargando…
Current Trend in Antiviral Therapy for Chronic Hepatitis B
Since active hepatitis B virus (HBV) replication is the key driver of hepatic necroinflammation and disease progression, the treatment aim of chronic hepatitis B (CHB) is to suppress HBV replication permanently to prevent hepatic decompensation, liver cirrhosis and/or hepatocellular carcinoma and pr...
Autores principales: | Chien, Rong-Nan, Liaw, Yun-Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877417/ https://www.ncbi.nlm.nih.gov/pubmed/35216027 http://dx.doi.org/10.3390/v14020434 |
Ejemplares similares
-
Current Antiviral Therapy for Chronic Hepatitis B
por: Lim, Young-Suk, et al.
Publicado: (2004) -
Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies
por: Su, Yi-Tse, et al.
Publicado: (2022) -
Antiviral therapy for chronic hepatitis B in China
por: Zheng, Xin, et al.
Publicado: (2014) -
Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety
por: Lam, Yuk-Fai, et al.
Publicado: (2011) -
Adverse effects of oral antiviral therapy in chronic hepatitis B
por: Kayaaslan, Bircan, et al.
Publicado: (2017)